281 related articles for article (PubMed ID: 9395198)
21. Toxic effects of fumonisin in mouse liver are independent of the peroxisome proliferator-activated receptor alpha.
Voss KA; Liu J; Anderson SP; Dunn C; Miller JD; Owen JR; Riley RT; Bacon CW; Corton JC
Toxicol Sci; 2006 Jan; 89(1):108-19. PubMed ID: 16221962
[TBL] [Abstract][Full Text] [Related]
22. WY-14,643 induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase.
Woods CG; Burns AM; Bradford BU; Ross PK; Kosyk O; Swenberg JA; Cunningham ML; Rusyn I
Toxicol Sci; 2007 Aug; 98(2):366-74. PubMed ID: 17483499
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms for the pancreatic oncogenic effects of the peroxisome proliferator Wyeth-14,643.
Obourn JD; Frame SR; Bell RH; Longnecker DS; Elliott GS; Cook JC
Toxicol Appl Pharmacol; 1997 Aug; 145(2):425-36. PubMed ID: 9266817
[TBL] [Abstract][Full Text] [Related]
24. Dose-related effects of the hepatocarcinogen, Wy-14,643, on peroxisomes and cell replication.
Wada N; Marsman DS; Popp JA
Fundam Appl Toxicol; 1992 Jan; 18(1):149-54. PubMed ID: 1601204
[TBL] [Abstract][Full Text] [Related]
25. Role of peroxisome proliferator-activated receptor alpha in altered cell cycle regulation in mouse liver.
Peters JM; Aoyama T; Cattley RC; Nobumitsu U; Hashimoto T; Gonzalez FJ
Carcinogenesis; 1998 Nov; 19(11):1989-94. PubMed ID: 9855014
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats.
Biegel LB; Hurtt ME; Frame SR; O'Connor JC; Cook JC
Toxicol Sci; 2001 Mar; 60(1):44-55. PubMed ID: 11222872
[TBL] [Abstract][Full Text] [Related]
27. The nongenotoxic hepatocarcinogen Wy-14,643 is an uncoupler of oxidative phosphorylation in vivo.
Keller BJ; Bradford BU; Marsman DS; Cattley RC; Popp JA; Bojes HK; Thurman RG
Toxicol Appl Pharmacol; 1993 Mar; 119(1):52-8. PubMed ID: 8470123
[TBL] [Abstract][Full Text] [Related]
28. Dietary glycine prevents the development of liver tumors caused by the peroxisome proliferator WY-14,643.
Rose ML; Cattley RC; Dunn C; Wong V; Li X; Thurman RG
Carcinogenesis; 1999 Nov; 20(11):2075-81. PubMed ID: 10545408
[TBL] [Abstract][Full Text] [Related]
29. The peroxisome proliferators are hepatocyte mitogens in chemically-defined media: glucocorticoid-induced PPAR alpha is linked to peroxisome proliferator mitogenesis.
Plant NJ; Horley NJ; Savory RL; Elcombe CR; Gray TJ; Bell DR
Carcinogenesis; 1998 May; 19(5):925-31. PubMed ID: 9635884
[TBL] [Abstract][Full Text] [Related]
30. Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators.
Rusyn I; Yamashina S; Segal BH; Schoonhoven R; Holland SM; Cattley RC; Swenberg JA; Thurman RG
Cancer Res; 2000 Sep; 60(17):4798-803. PubMed ID: 10987289
[TBL] [Abstract][Full Text] [Related]
31. Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643.
Conway JG; Tomaszewski KE; Olson MJ; Cattley RC; Marsman DS; Popp JA
Carcinogenesis; 1989 Mar; 10(3):513-9. PubMed ID: 2924396
[TBL] [Abstract][Full Text] [Related]
32. TGF alpha differentially expressed in liver foci induced by diethylnitrosamine initiation and peroxisome proliferator promotion.
Miller RT; Cattley RC; Marsman DS; Lyght O; Popp JA
Carcinogenesis; 1995 Jan; 16(1):77-82. PubMed ID: 7530605
[TBL] [Abstract][Full Text] [Related]
33. Initiator-specific promotion of hepatocarcinogenesis by WY-14,643 and clofibrate.
Cattley RC; Kato M; Popp JA; Teets VJ; Voss KS
Carcinogenesis; 1994 Aug; 15(8):1763-6. PubMed ID: 8055661
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of action of the nongenotoxic peroxisome proliferators: role of the peroxisome proliferator-activator receptor alpha.
Gonzalez FJ; Peters JM; Cattley RC
J Natl Cancer Inst; 1998 Nov; 90(22):1702-9. PubMed ID: 9827524
[TBL] [Abstract][Full Text] [Related]
35. The peroxisome proliferations WY-14,643 and methylclofenapate induce hepatocyte ploidy alterations and ploidy-specific DNA synthesis in F344 rats.
Miller RT; Shah RS; Cattley RC; Popp JA
Toxicol Appl Pharmacol; 1996 Jun; 138(2):317-23. PubMed ID: 8658533
[TBL] [Abstract][Full Text] [Related]
36. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
Peters JM; Zhou YC; Ram PA; Lee SS; Gonzalez FJ; Waxman DJ
Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121
[TBL] [Abstract][Full Text] [Related]
37. Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver.
Belury MA; Moya-Camarena SY; Sun H; Snyder E; Davis JW; Cunningham ML; Vanden Heuvel JP
Toxicol Appl Pharmacol; 1998 Aug; 151(2):254-61. PubMed ID: 9707502
[TBL] [Abstract][Full Text] [Related]
38. Time course investigation of PPARalpha- and Kupffer cell-dependent effects of WY-14,643 in mouse liver using microarray gene expression.
Woods CG; Kosyk O; Bradford BU; Ross PK; Burns AM; Cunningham ML; Qu P; Ibrahim JG; Rusyn I
Toxicol Appl Pharmacol; 2007 Dec; 225(3):267-77. PubMed ID: 17950772
[TBL] [Abstract][Full Text] [Related]
39. Perturbation of rodent hepatocyte growth control by nongenotoxic hepatocarcinogens: mechanisms and lack of relevance for human health (review).
Chevalier S; Roberts RA
Oncol Rep; 1998; 5(6):1319-27. PubMed ID: 9769363
[TBL] [Abstract][Full Text] [Related]
40. Induction of sister chromatid exchange and micronuclei in primary cultures of rat and human hepatocytes by the peroxisome proliferator, Wy-14,643.
Hwang JJ; Hsia MT; Jirtle RL
Mutat Res; 1993 Apr; 286(2):123-33. PubMed ID: 7681523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
